Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Free Cash Flow Generation Index
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Free Cash Flow Generation Index of 0.07x as of September 2025. Free cash flow of CN¥5.81 Million represents 0% of operating cash flow (CN¥88.00 Million). Explore Guangdong Zhongsheng Pharmaceutical Co L capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Guangdong Zhongsheng Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Guangdong Zhongsheng Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Guangdong Zhongsheng Pharmaceutical Co L operating cash flow efficiency.
Annual Free Cash Flow Generation for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Guangdong Zhongsheng Pharmaceutical Co Ltd. Check 002317 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.32x | CN¥109.58 Million | CN¥337.84 Million | CN¥228.26 Million | ▲ +135.9% |
| 2023 | -0.90x | CN¥-172.44 Million | CN¥190.61 Million | CN¥363.06 Million | ▲ +72.2% |
| 2022 | -3.25x | CN¥-204.89 Million | CN¥63.07 Million | CN¥267.96 Million | ▼ -594.7% |
| 2021 | 0.66x | CN¥409.00 Million | CN¥622.77 Million | CN¥213.76 Million | ▲ +688.6% |
| 2020 | -0.11x | CN¥-15.50 Million | CN¥138.93 Million | CN¥154.43 Million | ▼ -122.8% |
| 2019 | 0.49x | CN¥122.83 Million | CN¥251.16 Million | CN¥128.33 Million | ▼ -12.8% |
| 2018 | 0.56x | CN¥183.31 Million | CN¥326.78 Million | CN¥143.48 Million | ▼ -15.5% |
| 2017 | 0.66x | CN¥245.62 Million | CN¥369.91 Million | CN¥124.28 Million | ▲ +14.0% |
| 2016 | 0.58x | CN¥197.10 Million | CN¥338.28 Million | CN¥141.19 Million | ▼ -3.2% |
| 2015 | 0.60x | CN¥115.68 Million | CN¥192.25 Million | CN¥76.57 Million | ▲ +161.2% |
| 2014 | -0.98x | CN¥-98.95 Million | CN¥100.60 Million | CN¥199.54 Million | ▼ -11243.5% |
| 2013 | -0.01x | CN¥-962.04K | CN¥110.95 Million | CN¥111.91 Million | ▼ -101.9% |
| 2012 | 0.46x | CN¥64.96 Million | CN¥142.38 Million | CN¥77.42 Million | ▲ +128.0% |
| 2011 | -1.63x | CN¥-114.85 Million | CN¥70.56 Million | CN¥185.41 Million | ▼ -704.5% |
| 2010 | 0.27x | CN¥24.70 Million | CN¥91.72 Million | CN¥67.02 Million | ▼ -65.2% |
| 2009 | 0.77x | CN¥78.06 Million | CN¥100.89 Million | CN¥22.83 Million | ▲ +5.6% |
| 2008 | 0.73x | CN¥53.37 Million | CN¥72.86 Million | CN¥19.49 Million | ▲ +52.6% |
| 2007 | 0.48x | CN¥23.69 Million | CN¥49.35 Million | CN¥25.67 Million | ▲ +6.5% |
| 2006 | 0.45x | CN¥8.07 Million | CN¥17.91 Million | CN¥9.84 Million | — |